Clinical Trial Update: Effects of Fimasartan on Insulin Secretion in Type 2 Diabetic Patients [NA]

View source ↗

Summary

Completed clinical trial evaluating the effects of fimasartan on insulin secretion in patients with type 2 diabetes mellitus and hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Fimasartan (fimasartan)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Diabetes Mellitus, Hypertension | NA | Status: COMPLETED